Shelley Moore Capito bought Novo Nordisk A/S (NYSE: NVO)
Shelley Moore Capito (R-WV), a U.S. Senator, has disclosed 2 trades in Novo Nordisk A/S (NVO) since 2017, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Shelley Moore Capito bought $1,001 - $15,000 of Novo Nordisk A/S (NYSE: NVO) on September 8, 2017. Since that trade, NVO is up +160.27% against the S&P 500 up +239.51%, an outperformance of -79.24%.
Across these filings, Shelley Moore Capito has been a balanced trader of NVO (a buy-to-sell ratio of 1.00). The most recent disclosed NVO transaction shown was dated March 11, 2019. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Shelley Moore Capito's NVO trades vs the price
NVO is up +160.27% since Shelley Moore Capito bought on September 8, 2017, versus +239.51% for the S&P 500.
Performance since this trade
All Shelley Moore Capito NVO trades
Shelley Moore Capito & NVO trading FAQ
Is it legal for Shelley Moore Capito to trade Novo Nordisk A/S (NVO) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novo Nordisk A/S (NVO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Shelley Moore Capito buy NVO?
Shelley Moore Capito disclosed a purchase of $1,001 - $15,000 of Novo Nordisk A/S (NVO) on September 8, 2017, according to public STOCK Act filings.
How has NVO performed since Shelley Moore Capito's trade?
Since Shelley Moore Capito bought NVO on September 8, 2017, the stock is up +160.27%, versus +239.51% for the S&P 500 over the same period, an outperformance of -79.24%.
How many times has Shelley Moore Capito traded NVO?
Shelley Moore Capito has disclosed 2 NVO trades since 2017 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVO trades?
Quantellect tracks every disclosed congressional trade in Novo Nordisk A/S (NVO) on the Novo Nordisk A/S congressional trading page, which aggregates filings across all members of Congress.
Shelley Moore Capito's NVO tradesAll congressional filings for Novo Nordisk A/SShelley Moore Capito's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.